Learn To Invest

Stock Reports Quote and News Current Research View Research Archive Stock Charts Key Measures Business Summary Historical Financials Dividend History Balance Sheet Issued Capital Liquidity Peer Analysis Warrants Directors Interest Substantial Shareholders Interim Data Announcements Segment Performance

Stocks

ASX Market Report Overseas Market Report YMW Issue Newsletter Archive Research Archive Rating Changes Current Ratings Analyst Searches Corporate Calendar Upcoming Dividends Upcoming Floats Stock Screener ASX300 News Digest Our Research Methodology Model Income Portfolio Best Stock Ideas

Special Reports LICs Credit Funds ETFs Tools SMSFs Video Archive Article Archive About

Company News Summary

ResMed Announces Results for the Third Quarter of FY2021

30 Apr 2021 | 08:16:00 | Associate analysts | Increase | Decrease |

Original announcement: ResMed Announces Results for the Third Quarter of FY2021

ResMed announced results for the third quarter of FY 2021. Net operating profit increased 3%; non-GAAP operating profit up 2%. GAAP diluted earnings (loss) per share of $(0.54); non-GAAP diluted earnings per share of $1.30.

Please click here for full details

See more ASX300 News Announcements

Investor Pricing Help Advertising Opportunities Licensing Opportunities Glossary Financial Services Guide (AU) Financial Advice Provider Disclosure Statement (NZ) Contact Us Careers Research Report Disclosure Research Methodology

International Sites: United States Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K.

© Copyright 2022 Morningstar, Inc. All rights reserved. Please read our Terms of Use | Privacy Policy | Sitemap